Erythropoiesis-stimulating agents (ESAs)
Title
Date Published
Managing anemia in lymphoma and multiple myeloma.
April 1, 2008
Erythropoietin-stimulating agents in oncology.
March 31, 2008
C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.
February 20, 2008
The role of recombinant erythropoietin in childhood cancer.
February 1, 2008
Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
February 1, 2008
Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
January 28, 2008
Model predictive control of erythropoietin administration in the anemia of ESRD.
January 1, 2008
Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer.
January 1, 2008
Novel Erythropoiesis-Stimulating Agents: A New Era in Anemia Management.
December 12, 2007
Lack of functional erythropoietin receptors of cancer cell lines.
November 7, 2007
Impact of erythropoietin on allogenic blood exposure in orthopedic surgery.
November 1, 2007
Erythropoietin pharmacology.
November 1, 2007
Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing therapies.
November 1, 2007
Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signalling effects.
October 29, 2007
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.
October 22, 2007
Dose and cost comparison of erythropoietic agents in the inpatient hospital setting.
September 15, 2007
Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
September 14, 2007
Survival and erythropoietin receptor protein in tumours from patients randomly treated with rhEPO for palliative care.
September 11, 2007
Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
August 14, 2007
Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
July 31, 2007